Showing 2781-2790 of 3223 results for "".
- Biden Builds Out Health Team with Xavier Becerra Named to Lead HHShttps://modernod.com/news/biden-builds-out-health-team-with-xavier-becerra-named-to-lead-hhs/2478635/US President-elect Joe Biden released more of his health team picks on Monday, nominating California Attorney General Xavier Becerra to serve as Secretary of Health and Human Services (HHS). In addition, Vivek Murthy, who was the US Surgeon General from 2014 to 2017, has been selected to return t
- Your Patient Plans to Travel Despite COVID-19 Risk? Here’s the Latest CDC Guidance to Sharehttps://modernod.com/news/your-patient-plans-to-travel-despite-covid-19-risk-heres-the-latest-cdc-guidance-to-share/2478627/Make no mistake: Federal officials recommend the American public stay home over the upcoming holidays in order to stem the spread of the COVID-19 pandemic. Cases of COVID-19 are surging across the country and flooding—in some cases, overwhelming—hospitals, pushing many to postpone elective
- Topcon Announces the US Launch of RDx Telehealth Software Platformhttps://modernod.com/news/topcon-announces-the-us-launch-of-rdx-telehealth-software-platform/2478617/Topcon Healthcare announced that it has launched its new Topcon RDx ocular telehealth software platform in the US market. Topcon RDx is an eye health exam platform that allows practitioners to connect to their office remotely and conduct comprehensive eye exams in real-time from virtual
- Medicare Cuts Jeopardize Patient Care and Ignore Impacts of Pandemichttps://modernod.com/news/medicare-cuts-jeopardize-patient-care-and-ignore-impacts-of-pandemic/2478611/The Medicare Physician Fee Schedule (MPFS) final rule released today by the Centers for Medicare & Medicaid Services (CMS) will harm patients and further destabilize a health care system already under severe strain from the pandemic, according to a Surgical Care Coalition news release.
- Roche Receives FDA Emergency Use Authorization for New COVID-19 Antibodies Testhttps://modernod.com/news/roche-receives-fda-emergency-use-authorization-for-new-covid-10-antibodies-test/2478610/Roche announced that its Elecsys Anti-SARS-CoV-2 S antibody test has received Emergency Use Authorization (EUA) from the FDA. The semi-quantitative serology (blood) test can be used to measure the level of antibodies in people who have been exposed to the SARS-CoV-2 virus. The new test tar
- Orbis International Announces Mary Jane Jamar as First Chief Human Resources Officerhttps://modernod.com/news/orbis-international-announces-mary-jane-jamar-as-first-chief-human-resources-officer/2478605/Orbis has named Mary Jane Jamar as the organization’s first Chief Human Resources Officer (CHRO). In this capacity, Ms. Jamar will also join and play a critical role on the Orbis Executive Leadership Team.
- Report: Dry Eye Treatment Devices Market Size Worth $400.8 Million By 2027https://modernod.com/news/report-dry-eye-treatment-devices-market-size-worth-400-8-million-by-2027/2478591/The global dry eye treatment devices market size is estimated to reach US$400.8 million by 2027, expanding at a CAGR of 6.4%, according to a new report by Grand View Research, Inc. The increasing demand for targeted, noninvasive, faster, and patient compliant treatment methods to alleviate dry ey
- FDA Authorizes Regeneron’s Dual COVID-19 Antibody Treatment for Emergency Usehttps://modernod.com/news/fda-authorizes-regenerons-dual-covid-19-antibody-treatment-for-emergency-use/2478587/The FDA has issued an emergency-use authorization (EUA) to Regeneron’s filing for casirivimab and imdevimab to be administered together to treat mild-to-moderate COVID-19 in adults and paediatric patients. The monoclonal antibodies, also referred to as REGN-COV2 or as REGEN-COV2 when used i
- SIFI Completes Enrollment of the Phase 3 Study of Polihexanide 0.08% for the Treatment of Acanthamoeba Keratitishttps://modernod.com/news/sifi-completes-enrollment-of-the-phase-3-study-of-polihexanide-0-08-for-the-treatment-of-acanthamoeba-keratitis/2478575/SIFI announced that it has achieved the full enrollment of 135 patients with Acanthamoeba keratitis (AK) in its pivotal phase 3 clinical trial (043/SI). The full enrollment in the trial is an important milestone in addressing the unmet need for treating AK infections. It also paves the way
- Azar Expects 40M COVID-19 Vaccine Doses Ready to Distribute By End of Decemberhttps://modernod.com/news/azar-expects-40m-covid-19-vaccine-doses-ready-to-distribute-by-end-of-december/2478576/Department of Health and Human Services Secretary Alex Azar expects 40 million doses of Pfizer and Moderna’s COVID-19 vaccines will be ready for distribution by the end of December as providers must gear up now to allocate the doses, according to a FierceHealthcare